EMERYVILLE, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company developing cell therapies for patients with autoimmune diseases, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results